These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 18311066

  • 1. [Clinical efficacy of kanamycin for Mycobacterium avium complex disease].
    Suzuki A, Nishimura T, Ohtawa S, Mikami J, Kurashima A, Saito M, Mita M.
    Yakugaku Zasshi; 2008 Mar; 128(3):451-60. PubMed ID: 18311066
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Efficacy of clarithromycin and ethambutol for Mycobacterium avium complex pulmonary disease. A preliminary study.
    Miwa S, Shirai M, Toyoshima M, Shirai T, Yasuda K, Yokomura K, Yamada T, Masuda M, Inui N, Chida K, Suda T, Hayakawa H.
    Ann Am Thorac Soc; 2014 Jan; 11(1):23-9. PubMed ID: 24298907
    [Abstract] [Full Text] [Related]

  • 5. A double-blind randomized study of aminoglycoside infusion with combined therapy for pulmonary Mycobacterium avium complex disease.
    Kobashi Y, Matsushima T, Oka M.
    Respir Med; 2007 Jan; 101(1):130-8. PubMed ID: 16750618
    [Abstract] [Full Text] [Related]

  • 6. Relationship between clinical efficacy for pulmonary MAC and drug-sensitivity test for isolated MAC in a recent 6-year period.
    Kobashi Y, Abe M, Mouri K, Obase Y, Kato S, Oka M.
    J Infect Chemother; 2012 Aug; 18(4):436-43. PubMed ID: 22205543
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The clinical efficacy and safety of a fluoroquinolone-containing regimen for pulmonary MAC disease.
    Fujita M, Kajiki A, Tao Y, Miyazaki M, Ouchi H, Harada E, Ikegame S, Matsumoto T, Uchino J, Watanabe K, Nakanishi Y.
    J Infect Chemother; 2012 Apr; 18(2):146-51. PubMed ID: 21927844
    [Abstract] [Full Text] [Related]

  • 9. The clinical efficacy of a clarithromycin-based regimen for Mycobacterium avium complex disease: A nationwide post-marketing study.
    Kadota JI, Kurashima A, Suzuki K.
    J Infect Chemother; 2017 May; 23(5):293-300. PubMed ID: 28254517
    [Abstract] [Full Text] [Related]

  • 10. Impact of rifampicin on the pharmacokinetics of clarithromycin and 14-hydroxy clarithromycin in patients with multidrug combination therapy for pulmonary Mycobacterium avium complex infection.
    Iketani O, Komeya A, Enoki Y, Taguchi K, Uno S, Uwamino Y, Matsumoto K, Kizu J, Hasegawa N.
    J Infect Chemother; 2022 Jan; 28(1):61-66. PubMed ID: 34706852
    [Abstract] [Full Text] [Related]

  • 11. Effective treatment for clarithromycin-resistant Mycobacterium avium complex lung disease.
    Adachi Y, Tsuyuguchi K, Kobayashi T, Kurahara Y, Yoshida S, Kagawa T, Hayashi S, Suzuki K.
    J Infect Chemother; 2020 Jul; 26(7):676-680. PubMed ID: 32171660
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of clinical features in patients with pulmonary Mycobacterium-avium complex (MAC) disease treated before and after proposal for guidelines.
    Kobashi Y, Matsushima T.
    J Infect Chemother; 2004 Feb; 10(1):25-30. PubMed ID: 14991514
    [Abstract] [Full Text] [Related]

  • 15. [Strategies for Mycobacterium avium complex infection control in Japan: how do they improve the present situation?].
    Ogawa K, Sano C.
    Kekkaku; 2013 Mar; 88(3):355-71. PubMed ID: 23672176
    [Abstract] [Full Text] [Related]

  • 16. Macrolide resistant Mycobacterium avium complex pulmonary disease following clarithromycin and ethambutol combination therapy.
    Ito Y, Miwa S, Shirai M, Kanai M, Fujita K, Ohba H, Iwaizumi E, Oshima T, Kojima S, Suda T, Hayakawa H.
    Respir Med; 2020 Aug; 169():106025. PubMed ID: 32442113
    [Abstract] [Full Text] [Related]

  • 17. Activity of KRM-1648 alone or in combination with both ethambutol and kanamycin or clarithromycin against Mycobacterium intracellulare infections in beige mice.
    Yamamoto T, Amitani R, Suzuki K, Tanaka E, Murayama T, Kuze F.
    Antimicrob Agents Chemother; 1996 Feb; 40(2):429-32. PubMed ID: 8834892
    [Abstract] [Full Text] [Related]

  • 18. [A study on the effect of combined chemotherapy on Mycobacterium avium complex pulmonary disease].
    Sato K, Ebe T.
    Kekkaku; 2000 Jul; 75(7):471-6. PubMed ID: 10944891
    [Abstract] [Full Text] [Related]

  • 19. [The clinical study on efficacy of clarithromycin, levofloxacin, and streptomycin for pulmonary Mycobacterium avium-intracellulare complex infection].
    Taga S, Ogawa K, Nakagawa T, Tano M.
    Kekkaku; 2005 Jan; 80(1):1-7. PubMed ID: 15839056
    [Abstract] [Full Text] [Related]

  • 20. A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group.
    Shafran SD, Singer J, Zarowny DP, Phillips P, Salit I, Walmsley SL, Fong IW, Gill MJ, Rachlis AR, Lalonde RG, Fanning MM, Tsoukas CM.
    N Engl J Med; 1996 Aug 08; 335(6):377-83. PubMed ID: 8676931
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.